Who
Gary Charles Robb
Chief Business Officer
Company insider
Files Form 4 as: Chief Business Officer, Corcept Therapeutics.
In numbers
- Trades disclosed
- 251
- Buys
- 1
- Sells
- 34
- Bought
- $55K
- Sold
- $16.1M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Sep 2011
- Last trade
- 24 Sep 2026
- Last filed
- 28 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 24 Sep 2026filed 28 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code G | —17,100 at $0.00 | filing |
| 24 Sep 2026filed 28 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code G | —5,000 at $0.00 | filing |
| 24 Sep 2026filed 28 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code G | —5,000 at $0.00 | filing |
| 24 Sep 2026filed 28 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code G | —17,100 at $0.00 | filing |
| 24 Sep 2026filed 28 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code G | —5,000 at $0.00 | filing |
| 24 Sep 2026filed 28 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code G | —5,000 at $0.00 | filing |
| 17 Sep 2026filed 18 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code M | $145K17,493 at $8.27 | filing |
| 17 Sep 2026filed 18 Sep 2026 | CORT Corcept Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —17,493 at $0.00 | filing |
| 17 Sep 2026filed 18 Sep 2026 | CORT Corcept Therapeuticsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —17,493 at $0.00 | filing |
| 17 Sep 2026filed 18 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code M | $145K17,493 at $8.27 | filing |
| 2 Sep 2026filed 3 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code F | $10K91 at $113.38 | filing |
| 2 Sep 2026filed 3 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code F | $10K91 at $113.38 | filing |
| 1 Sep 2026filed 3 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code A | $19K164 at $113.38 | filing |
| 1 Sep 2026filed 3 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code A | —164 at $0.00 | filing |
| 1 Sep 2026filed 3 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code A | $19K164 at $113.38 | filing |
| 1 Sep 2026filed 3 Sep 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code A | —164 at $0.00 | filing |
| 17 Aug 2026filed 18 Aug 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code G | —125 at $0.00 | filing |
| 17 Aug 2026filed 18 Aug 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $1.2M10,000 at $116.26 | filing |
| 17 Aug 2026filed 18 Aug 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Code G | —125 at $0.00 | filing |
| 17 Aug 2026filed 18 Aug 2026 | CORT Corcept TherapeuticsPharmaceuticals | SEC FORM 4 Sold | $1.2M10,000 at $116.26 | filing |
News
Corcept Therapeutics (NASDAQ:CORT) Stock Falls 14.5% – Should You Sell?CORT · themarketsdaily.com · 23 Oct 2026Corcept Therapeutics (NASDAQ:CORT) vs. Ovid Therapeutics (NASDAQ:OVID) Head-To-Head ContrastCORT · themarketsdaily.com · 15 Oct 2026
0 headlines in the last 90 days name Gary Charles Robb; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.